These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34646654)

  • 1. Combined Phacoemulsification and Intravitreal Dexamethasone Is an Effective Option for High-Risk Diabetic Macula Oedema Patients.
    Thirunavukarasu AJ; Malem A; Mourtzoukos S
    Cureus; 2021 Aug; 13(8):e17603. PubMed ID: 34646654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema.
    Mehta H; Gillies M; Fraser-Bell S
    Ther Adv Chronic Dis; 2015 Sep; 6(5):234-45. PubMed ID: 26336592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification.
    Sze AM; Luk FO; Yip TP; Lee GK; Chan CK
    Eur J Ophthalmol; 2015; 25(2):168-72. PubMed ID: 25363857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The UK Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group, Report 2: real-world data for the impact of cataract surgery on diabetic macular oedema.
    Denniston AK; Chakravarthy U; Zhu H; Lee AY; Crabb DP; Tufail A; Bailey C; Akerele T; Al-Husainy S; Brand C; Downey L; Fitt A; Khan R; Kumar V; Lobo A; Mahmood S; Mandal K; Mckibbin M; Menon G; Natha S; Ong JM; Tsaloumas MD; Varma A; Wilkinson E; Johnston RL; Egan CA;
    Br J Ophthalmol; 2017 Dec; 101(12):1673-1678. PubMed ID: 28487377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomised controlled clinical trial comparing a combination of repeated intravitreal Ozurdex and macular laser therapy versus macular laser only in centre-involving diabetic macular oedema (OZLASE study).
    Heng LZ; Sivaprasad S; Crosby-Nwaobi R; Saihan Z; Karampelas M; Bunce C; Peto T; Hykin PG
    Br J Ophthalmol; 2016 Jun; 100(6):802-7. PubMed ID: 26472406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract.
    Akinci A; Muftuoglu O; Altınsoy A; Ozkılıc E
    Retina; 2011 Apr; 31(4):755-8. PubMed ID: 21124251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy and duration of action of dexamethasone implant, in vitrectomised and non-vitrectomised eyes with persistent diabetic macular oedema.
    Bastakis GG; Dimopoulos D; Stavrakakis A; Pappas G
    Eye (Lond); 2019 Mar; 33(3):411-418. PubMed ID: 30302004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabeticfoveal oedema and cataract.
    Habib MS; Cannon PS; Steel DH
    BMC Ophthalmol; 2005 Jun; 5():15. PubMed ID: 15972106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone Intravitreal Implant in the Treatment of Uveitic Macular Edema in the Perioperative Cataract Setting: A Case Series.
    Larochelle MB; Smith J; Dacey MS
    Am J Ophthalmol; 2016 Jun; 166():149-153. PubMed ID: 27066725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic macular oedema: a 6-month prospective pilot study.
    Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Lai WW; Fan DS; Chan WM
    Eye (Lond); 2005 Aug; 19(8):885-90. PubMed ID: 15389275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phacoemulsification with intravitreal bevacizumab injection in diabetic patients with macular edema and cataract.
    Akinci A; Batman C; Ozkilic E; Altinsoy A
    Retina; 2009; 29(10):1432-5. PubMed ID: 19898181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic Macular Edema at the time of Cataract Surgery trial: a prospective, randomized clinical trial of intravitreous bevacizumab versus triamcinolone in patients with diabetic macular oedema at the time of cataract surgery - preliminary 6 month results.
    Lim LL; Morrison JL; Constantinou M; Rogers S; Sandhu SS; Wickremasinghe SS; Kawasaki R; Al-Qureshi S
    Clin Exp Ophthalmol; 2016 May; 44(4):233-42. PubMed ID: 26871700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acuity and colour vision changes post intravitreal dexamethasone implant injection in patients with diabetic macular oedema.
    Abdel-Hay A; Sivaprasad S; Subramanian A; Barbur JL
    PLoS One; 2018; 13(6):e0199693. PubMed ID: 29944702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study.
    Mansour SE; Kiernan DF; Roth DB; Eichenbaum D; Holekamp NM; Kaba S; Werts E
    Br J Ophthalmol; 2021 Mar; 105(3):414-419. PubMed ID: 32461262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of topical nepafenac in prevention of macular edema after cataract surgery in patients with non-proliferative diabetic retinopathy.
    Sarfraz MH; Haq RI; Mehboob MA
    Pak J Med Sci; 2017; 33(1):210-214. PubMed ID: 28367202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of intravitreal bevacizumab and phacoemulsification surgery in patients with cataract and coexisting diabetic macular edema.
    Chen CH; Liu YC; Wu PC
    J Ocul Pharmacol Ther; 2009 Feb; 25(1):83-9. PubMed ID: 19232012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex®) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema.
    Furino C; Boscia F; Niro A; Giancipoli E; Grassi MO; D'amico Ricci G; Blasetti F; Reibaldi M; Alessio G
    J Ophthalmol; 2017; 2017():4896036. PubMed ID: 28884024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal injection of ranibizumab during cataract surgery in patients with diabetic macular edema.
    Rauen PI; Ribeiro JA; Almeida FP; Scott IU; Messias A; Jorge R
    Retina; 2012 Oct; 32(9):1799-803. PubMed ID: 22495327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracrystalline Ozurdex
    Clemente-Tomás R; Hernández-Pérez D; Neira-Ibáñez P; Farías-Rozas F; Torrecillas-Picazo R; Osorio-Alayo V; Duch-Samper AM
    Int Ophthalmol; 2019 Jan; 39(1):207-211. PubMed ID: 29192395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating Diabetic Macular Oedema (DMO): real world UK clinical outcomes for the 0.19mg Fluocinolone Acetonide intravitreal implant (Iluvien™) at 2 years.
    Fusi-Rubiano W; Mukherjee C; Lane M; Tsaloumas MD; Glover N; Kidess A; Denniston AK; Palmer HE; Manna A; Morjaria R
    BMC Ophthalmol; 2018 Feb; 18(1):62. PubMed ID: 29486754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.